A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Compounding pharmacies make their own versions of weight loss drugs at a fraction of the price but there are some drawbacks.

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...